FIGURE 4.

Pathway of short‐term insulin therapies for older T2DM patients. HbA_1c, glycated hemoglobin; T2DM, Type 2 diabetes mellitus. In terms of insulin, both human insulin and insulin analogues are included, and insulin analogues should be preferred. Premixed insulin analogues can be administered three times a day, whereas premixed human insulin cannot. Non‐insulin therapy may be discontinued during the short‐term insulin therapy. Once the hyperglycemic state is relieved, the treatment strategy should be re‐evaluated and optimized.